| Mar 24 2020 |
FDA Eases Device Modification Rules to Expand Availability of Ventilators During COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
| Mar 24 2020 |
COVID-19 – Legal Implications for Pharmaceutical and Medical Device Companies in Germany |
McDermott Will & Schulte LLP |
| Mar 24 2020 |
FDA Offers Guidance on Clinical Trials During COVID-19 Pandemic |
McDermott Will & Schulte LLP |
| Mar 24 2020 |
FDA Confirms That At-Home Collection Kits Are Not Authorized for Use with COVID-19 Tests |
Epstein Becker & Green, P.C. |
| Mar 24 2020 |
The Global Patent Race for a COVID-19 Vaccine |
Summa PLLC |
| Mar 23 2020 |
FDA’s Role in Battling the COVID-19 Pandemic: Part I What Manufacturers, Diagnostic Laboratories and Their Insurers Need to Know |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 23 2020 |
TTB and FDA Relax Restrictions on the Production of Hand Sanitizers by Alcohol Manufacturers |
McDermott Will & Schulte LLP |
| Mar 23 2020 |
Antitrust Enforcers Target Coronavirus-related Violations |
Proskauer Rose LLP |
| Mar 23 2020 |
US EPA Issues List of Disinfectants Qualified for Use Against COVID-19 and Initiates Expedited Review Process for Approving Product Claims Against the Virus |
Squire Patton Boggs (US) LLP |
| Mar 23 2020 |
Attack on PFASs Extends to Food Packaging |
Keller and Heckman LLP |
| Mar 23 2020 |
U.S. DOT Issues Guidance Regarding Drug And Alcohol Testing During COVID-19 Crisis |
Jackson Lewis P.C. |
| Mar 23 2020 |
COVID-19: HHS Issues FAQs on HIPAA and Telehealth to Help Providers Maintain Access to Care During the Pandemic |
Robinson & Cole LLP |
| Mar 23 2020 |
Critical Infrastructure Worker Guidance Identifies Food & Agriculture Workers Broadly |
Keller and Heckman LLP |
| Mar 22 2020 |
EPA Issues Revised Method for Conducting Biological Evaluations of Pesticides under the Endangered Species Act |
Bergeson & Campbell, P.C. |
| Mar 20 2020 |
The Updated Rules on Joint Employment: A More Direct Approach and With Less Worry for Pharmaceutical Companies |
Norris McLaughlin P.A. |
| Mar 20 2020 |
FDA Issues Guidance on Temporary Policy Regarding FSMA and FSVP Onsite Audit Requirements Due to COVID-19 |
Keller and Heckman LLP |
| Mar 20 2020 |
COVID-19 Testing: Access Continues to Present Challenges Despite Recent Advances |
Greenberg Traurig, LLP |
| Mar 20 2020 |
FDA Scales Back Domestic Inspections in Response to the Coronavirus Pandemic |
Keller and Heckman LLP |
| Mar 20 2020 |
BRAG Biobased Products Blog: March 20, 2020 |
Bergeson & Campbell, P.C. |
| Mar 20 2020 |
Managing the Commercial Impact of Coronavirus: Emergency Order Relaxes Florida Licensure, Telehealth, and Practice Standards to Combat COVID-19 |
Foley & Lardner LLP |
| Mar 19 2020 |
Tort-Focused Legal Considerations for Healthcare Providers and Product Manufacturers in the COVID-19 Landscape |
Dinsmore & Shohl LLP |
| Mar 19 2020 |
Emergency Paid Sick Leave Enacted |
Vedder Price |
| Mar 19 2020 |
Can Coverage for COVID-19 Be Excluded? |
Squire Patton Boggs (US) LLP |
| Mar 19 2020 |
OCR Waives Penalties for Telehealth Communications During COVID-19 National Emergency |
Epstein Becker & Green, P.C. |
| Mar 19 2020 |
The Latest COVID-19 Conundrum: Can Employers Institute Temperature Checks at Workplaces? |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 19 2020 |
“Be Sure to Order it”: PETA and Beyond Meat Embroiled in New Multi-Million Dollar TCPA Class Action For Robotexts Pushing Fake Meat |
Troutman Amin, LLP |
| Mar 19 2020 |
FDA Issues Temporary Guidance on Food Supplier Verification Audit Requirements |
Epstein Becker & Green, P.C. |
| Mar 19 2020 |
ECHA Considers Additional Phthalate for REACH Authorization List; EFSA Publishes Updated Risk Assessment on Five Phthalates Authorized for Food Contact Plastics |
Keller and Heckman LLP |
| Mar 19 2020 |
Korea Notifies WTO Concerning Proposed Update to Food Packaging Standards |
Keller and Heckman LLP |
| Mar 19 2020 |
Coronavirus (COVID-19) Temporary Advisory Notice: Breaking Down the Latest Guidance From the Pennsylvania Liquor Control Board |
Norris McLaughlin P.A. |
| Mar 19 2020 |
COVID-19: Implications for Pharmaceutical and Medical Device Companies |
Dinsmore & Shohl LLP |
| Mar 19 2020 |
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
| Mar 19 2020 |
The Fun Did Stop for Pringles False Advertising Class Action |
Proskauer Rose LLP |
| Mar 19 2020 |
Families First Coronavirus Response Act: Guidance for Health Care Providers and Plans Regarding COVID-19 |
Epstein Becker & Green, P.C. |
| Mar 19 2020 |
COVID-19 Telehealth Guidance: What You Need to Know |
McDermott Will & Schulte LLP |
